Core Viewpoint - The company has successfully completed various inspections and obtained necessary permits for its corn protein processing project, which is expected to enhance production capacity and competitive advantage in the domestic feed enzyme protein sector, positively impacting revenue growth and operational quality [1] Group 1 - The company announced that its "annual production capacity of 100,000 tons of corn protein processing project" has completed fire acceptance, safety simultaneous acceptance, and completion acceptance [1] - The company has obtained pollution discharge permits for the project [1] - The wholly-owned subsidiary, Leiling Meinong, received a "Feed Production License" from the Shandong Provincial Animal Husbandry and Veterinary Bureau [1] Group 2 - The project is expected to expand the company's production scale [1] - The project will strengthen the company's competitive advantage in the domestic feed enzyme protein field [1] - The launch of related products is anticipated to have a positive impact on the company's revenue growth and operational quality [1]

Core Viewpoint - Meino Bio (301156.SZ) has made significant progress in its "annual production of 100,000 tons of corn protein deep processing project" by completing various inspections and obtaining necessary permits, which is expected to enhance its competitive advantage in the domestic feed enzymatic protein sector and positively impact revenue growth and operational quality [1][1][1] Group 1 - The company has completed fire acceptance, safety simultaneous acceptance, and completion acceptance for its corn protein project [1] - The company has obtained a pollution discharge permit, marking a critical milestone for the project [1] - The subsidiary, Leiling Meino, has received a feed production license from the Shandong Provincial Animal Husbandry and Veterinary Bureau [1] Group 2 - The project is expected to expand the company's production scale and strengthen its competitive position in the feed enzymatic protein market [1] - The investment aligns with the company's overall strategic planning and supports long-term high-quality development [1] - The investment does not harm the interests of the company or its shareholders, particularly minority shareholders [1]

证券日报网讯美农生物（301156）9月22日发布公告，在公司回答调研者提问时表示，公司全资子公司 乐陵美农于去年8月底注册成立，以实施公司10万吨玉米蛋白精加工项目。为尽早实现投产目标，公司 全面统筹资源，周密制定计划，积极协调各方力量，顺利完成了项目用地、立项核准、环评审批及施工 许可等关键手续。项目团队坚持高标准、快节奏推进建设工作，目前一期工程进展顺利，有望在今年内 建成并进入试生产阶段。 ...